Literature DB >> 1811374

Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate.

I Jacques1, V Olivier-Bernardin, G Dubray.   

Abstract

A Brucella conjugate vaccine was synthesized by covalently coupling the O-polysaccharide (PS) obtained from Brucella melitensis 16M, to bovine serum albumin (BSA). The conjugate (PS-BSA) was non-toxic for mice. When injected at two doses (10 or 1 micrograms) in mice, it induced the production of antibodies and the boost was shown to be efficient if administered after 10 weeks. Immunization of mice with 10 micrograms of conjugate conferred significant protection against virulent challenge with B. melitensis H38, similar to that obtained with the reference vaccine H38.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1811374     DOI: 10.1016/0264-410x(91)90010-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

2.  Cloning, nucleotide sequence, and expression of the gene coding for a ribosome releasing factor-homologous protein of Brucella melitensis.

Authors:  N Vizcaíno; A Cloeckaert; G Dubray; M S Zygmunt
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Authors:  J Kuo; M Douglas; H K Ree; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

4.  A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.

Authors:  María E Cortina; Rodrigo E Balzano; Diego A Rey Serantes; Ana J Caillava; Sebastián Elena; A C Ferreira; Ana M Nicola; Juan E Ugalde; Diego J Comerci; Andrés E Ciocchini
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

5.  Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.

Authors:  Apurba K Bhattacharjee; Mina J Izadjoo; Wendell D Zollinger; Mikeljon P Nikolich; David L Hoover
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

Authors:  N Vizcaíno; A Cloeckaert; M S Zygmunt; G Dubray
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

7.  O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  A Cloeckaert; V Weynants; J Godfroid; J M Verger; M Grayon; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

9.  Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins.

Authors:  A Tibor; V Weynants; P Denoel; B Lichtfouse; X De Bolle; E Saman; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.

Authors:  Apurba K Bhattacharjee; Lillian Van de Verg; Mina J Izadjoo; Liang Yuan; Ted L Hadfield; Wendell D Zollinger; David L Hoover
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.